Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactofferin as a marker
Details for Australian Patent Application No. 2007234504 (hide)
International Classifications
Event Publications
29 November 2007 Complete Application Filed
6 December 2007 Application Open to Public Inspection
Published as AU-B-2007234504
18 November 2010 Application Accepted
Published as AU-B-2007234504
9 December 2010 Application for Amendment
The nature of the amendment is: Amend co-inventor name from Guerrant, richard Littleton to Guerrant, Richard Littleton; wilkins, Tracy Dale to Wilkins, Tracy Dale. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
31 March 2011 Amendment Made
The nature of the amendment is: Amend the name of the inventor to read Guerrant, Richard Littleton; Lyerly, David Maxwell; Wilkins, Tracy Dale and Boone, James Hunter
31 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007234505-3-Hydroxypropionic acid and other organic compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser